Harnessing the immune system through programmed death-1 blockade in the management of Hodgkin lymphoma

por Oncale, Melody B, Maymani, Hossein, Nastoupil, Loretta J
Publicado 2017

Copanlisib for the Treatment of Malignant Lymphoma: Clinical Experience and Future Perspectives

por Munoz, Javier, Follows, George A., Nastoupil, Loretta J.
Publicado 2021

Exploring Risk Factors for Follicular Lymphoma

por Ambinder, Alexander J., Shenoy, Pareen J., Malik, Neha, Maggioncalda, Alison, Nastoupil, Loretta J., Flowers, Christopher R.
Publicado 2012

Radiation and CAR T-cell Therapy in Lymphoma: Future Frontiers and Potential Opportunities for Synergy

por Fang, Penny Q., Gunther, Jillian R., Wu, Susan Y., Dabaja, Bouthaina S., Nastoupil, Loretta J., Ahmed, Sairah, Neelapu, Sattva S., Pinnix, Chelsea C.
Publicado 2021

PB2276: MAHOGANY: A PHASE 3 TRIAL OF ZANUBRUTINIB PLUS ANTI-CD20 ANTIBODIES VS LENALIDOMIDE PLUS RITUXIMAB IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR OR MARGINAL ZONE LYMPH...

por Silvestre, Antonio Salar, Trotman, Judith, Sarkozy, Clementine, Song, Yuqin, Sehn, Laurie H., Nastoupil, Loretta J., Zhang, Wanhua, Fustier, Pierre, Delarue, Richard, Zinzani, Pier Luigi
Publicado 2023

Impact of histologic subtypes and treatment modality among patients with primary central nervous system lymphoma: a SEER database analysis

por Chihara, Dai, Fowler, Nathan H., Oki, Yasuhiro, Fanale, Michelle A., Nastoupil, Loretta J., Westin, Jason R., Fayad, Luis E., Neelapu, Sattva S., Cheah, Chan Yoon
Publicado 2018

Coincident primary breast lymphoma and gastrointestinal stromal tumor: case series and molecular mechanisms

por Ludmir, Ethan B, Gutschenritter, Tyler, Pinnix, Chelsea C, Gunther, Jillian R, Nastoupil, Loretta J, Khoury, Joseph D, Medeiros, L Jeffrey, Dabaja, Bouthaina S, Milgrom, Sarah A
Publicado 2018

The use and effectiveness of rituximab maintenance in patients with follicular lymphoma diagnosed between 2004 and 2007 in the United States

por Nastoupil, Loretta J, Sinha, Rajni, Byrtek, Michelle, Zhou, Xiaolei, Taylor, Michael D, Friedberg, Jonathan W, Link, Brian K, Cerhan, James R, Dawson, Keith, Flowers, Christopher R
Publicado 2014

P1092: A PHASE II INVESTIGATOR INITIATED STUDY OF ACALABRUTINIB, LENALIDOMIDE AND RITUXIMAB (AR2) IN PATIENTS WITH PREVIOUSLY UNTREATED HIGH TUMOR BURDEN FOLLICULAR LYMPHOMA

por Strati, Paolo, Feng, Lei, Westin, Jason, Nair, Ranjit, Gouni, Sushanth, Fayad, Luis, Rodriguez, Maria, Chihara, Dai, Malpica, Luis, Steiner, Raphael, Gallardo, Mariana, Nastoupil, Loretta J., Neelapu, Sattva
Publicado 2023

Prediction of Mortality Following Cytokine Storm in Patients with Hematological Malignancies and COVID-19 Infections

por Prakash, Rishab, Long, James, Edelkamp, Paul, Knafl, Mark, Ahmed, Sairah, Khawaja, Fareed, Nastoupil, Loretta J., Manzano, Joanna-Grace, Mulanovich, Victor, Prabhakaran, Sabitha, Futreal, Andrew, Woodman, Scott E, Iyer, Swaminathan Padmanabhan
Publicado 2022

Diffuse large B-cell lymphoma in very elderly patients over 80 years old: Incorporating consolidative radiation therapy into management decisions

por Pinnix, Chelsea C., Andraos, Therese Y., Dabaja, Bouthaina, Milgrom, Sarah, Smith, Grace, Chihara, Dai, Ng, Andrea, Fayad, Luis E., Oki, Yasuhiro, Neelapu, Sattva, Westin, Jason, Rodriguez, M. Alma, Nastoupil, Loretta J.
Publicado 2017

Follicular Lymphoma: Recent and Emerging Therapies, Treatment Strategies, and Remaining Unmet Needs

por Matasar, Matthew J., Luminari, Stefano, Barr, Paul M., Barta, Stefan K., Danilov, Alexey V., Hill, Brian T., Phillips, Tycel J., Jerkeman, Mats, Magagnoli, Massimo, Nastoupil, Loretta J., Persky, Daniel O., Okosun, Jessica
Publicado 2019

Partial omission of bleomycin for early‐stage Hodgkin lymphoma patients treated with combined modality therapy: Does incomplete ABVD lead to inferior outcomes?

por Gunther, Jillian R., Pinnix, Chelsea C., Glober, Gordon R., Christopherson, Kaitlin M., Fang, Penny, Lee, Hun Ju, Ahmed, Sairah, Steiner, Raphael E., Nair, Ranjit, Strati, Paolo, Neelapu, Sattva S., Nastoupil, Loretta J., Dabaja, Bouthaina S.
Publicado 2020

An international multicenter retrospective analysis of patients with extranodal marginal zone lymphoma and histologically confirmed central nervous system and dural involvement

por Sunderland, Andrew J., Steiner, Raphael E., Al Zahrani, Musa, Pinnix, Chelsea C., Dabaja, Bouthaina Shbib, Gunther, Jillian R., Nastoupil, Loretta J., Jerkeman, Mats, Joske, David, Cull, Gavin, El‐Galaly, Tarec, Villa, Diego, Cheah, Chan Yoon
Publicado 2019

Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic

por Bachanova, Veronika, Bishop, Michael R., Dahi, Parastoo, Dholaria, Bhagirathbhai, Grupp, Stephan A., Hayes-Lattin, Brandon, Janakiram, Murali, Maziarz, Richard T., McGuirk, Joseph P., Nastoupil, Loretta J., Oluwole, Olalekan O., Perales, Miguel-Angel, Porter, David L., Riedell, Peter A.
Publicado 2020

Pre-treatment maximum standardized uptake value predicts outcome after frontline therapy in patients with advanced stage follicular lymphoma

por Strati, Paolo, Ahmed, Mohamed Amin, Fowler, Nathan H., Nastoupil, Loretta J., Samaniego, Felipe, Fayad, Luis E., Hagemeister, Fredrick B., Romaguera, Jorge E., Rodriguez, Alma, Wang, Michael, Westin, Jason R., Cheah, Chan, Noorani, Mansoor, Feng, Lei, Davis, Richard E., Neelapu, Sattva S.
Publicado 2020

Safety and activity of pembrolizumab in combination with rituximab in relapsed or refractory follicular lymphoma

por Nastoupil, Loretta J., Chin, Collin K., Westin, Jason R., Fowler, Nathan H., Samaniego, Felipe, Cheng, Xiaoyun, Ma, Man Chun John, Wang, Zhiqiang, Chu, Fuliang, Dsouza, Ly, Obi, Chizobam, Mims, Jennifer, Feng, Lei, Zhou, Shouhao, Green, Michael, Davis, Richard Eric, Neelapu, Sattva S.
Publicado 2022

Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapy

por Wudhikarn, Kitsada, Tomas, Ana Alarcon, Flynn, Jessica R., Devlin, Sean M., Brower, Jamie, Bachanova, Veronika, Nastoupil, Loretta J., McGuirk, Joseph P., Maziarz, Richard T., Oluwole, Olalekan O., Schuster, Stephen J., Porter, David L., Bishop, Michael R., Riedell, Peter A., Perales, Miguel-Angel
Publicado 2022

P1107: ZUMA-22: A PHASE 3, RANDOMIZED CONTROLLED STUDY OF AXICABTAGENE CILOLEUCEL VERSUS STANDARD-OF-CARE THERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA

por Flinn, Ian W., Jacobson, Caron, Nastoupil, Loretta J., Morschhauser, Franck, Davies, Andrew J., Buske, Christian, Corradini, Paolo, Lopez-Guillermo, Armando, Reshef, Ran, Parameswaran, Vinod, Sehgal, Alison, Tees, Michael, Lui, Christine, Xue, Wei, Beygi, Sara, Grechko, Nikolay, Bolsue, Pisita, Giovanetti, Alessandro, To, Christina, Nahas, Myrna
Publicado 2023

Chimeric antigen receptor T-cell therapy yields similar outcomes in patients with and without cytokine release syndrome

por Bhaskar, Shakthi T., Patel, Vivek G., Porter, David L., Schuster, Stephen J., Nastoupil, Loretta J., Perales, Miguel-Angel, Tomas, Ana Alarcon, Bishop, Michael R., McGuirk, Joseph P., Maziarz, Richard T., Chen, Andy I., Bachanova, Veronika, Maakaron, Joseph E., Riedell, Peter A., Oluwole, Olalekan O.
Publicado 2022